Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

roche registration ltd, u.k. - methoxy polyethylene glycol-epoetin beta - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΣΕ ΠΡΟΓΕΜΙΣΜΕΝΗ ΣΥΡΙΓΓΑ - 360mcg/0,3ml pf.syr. - ΒΙΟΤΕΧΝΟΛΟΓΙΚΑ

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

roche registration gmbh - methoxy polyethylene glycol-epoetin beta - anemia; kidney failure, chronic - Αντινεμμικά παρασκευάσματα - treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adult patients (see section 5. treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in paediatric patients from 3 months to less than 18 years of age who are converting from another erythropoiesis stimulating agent (esa) after their haemoglobin level was stabilised with the previous esa (see section 5.